[Single and multiple applications and metabolite pattern of clenbuterol in man (author's transl)]
- PMID: 1036937
[Single and multiple applications and metabolite pattern of clenbuterol in man (author's transl)]
Similar articles
-
[Pharmacokinetics and metabolite pattern of clenbuterol in rabbit and dog (author's transl)].Arzneimittelforschung. 1976;26(7a):1442-5. Arzneimittelforschung. 1976. PMID: 1036936 German. No abstract available.
-
[Comparison of the pharmacokinetic profiles of clenbuterol in rat and dog during toxicological studies (author's transl)].Arzneimittelforschung. 1976;26(7a):1450-5. Arzneimittelforschung. 1976. PMID: 1036938 German.
-
Metabolism of isoprenaline and other bronchodilator drugs in man and dog.Bull Physiopathol Respir (Nancy). 1972 May-Jun;8(3):679-83. Bull Physiopathol Respir (Nancy). 1972. PMID: 4645577 No abstract available.
-
Metabolic studies of Salbutanol-3H: a new bronchodilator, in rat, rabbit, dog and man.Eur J Pharmacol. 1971 Apr;14(2):183-99. doi: 10.1016/0014-2999(71)90211-1. Eur J Pharmacol. 1971. PMID: 5164253 No abstract available.
-
The treatment of bronchial asthma.BTTA Rev. 1971 Dec;1(4):43-52. BTTA Rev. 1971. PMID: 4338363 Review. No abstract available.
Cited by
-
Clinical pharmacokinetics of beta-agonists.Clin Pharmacokinet. 1990 Apr;18(4):270-94. doi: 10.2165/00003088-199018040-00002. Clin Pharmacokinet. 1990. PMID: 1969785 Review.
-
Effects of clenbuterol, ICI118551 and sotalol on the growth of cardiac and skeletal muscle and on beta 2-adrenoceptor density in female rats.Naunyn Schmiedebergs Arch Pharmacol. 1991 Oct;344(4):449-53. doi: 10.1007/BF00172585. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1685013
-
Dose response relationship of clenbuterol (NAB 365) as a solution for inhalation.Eur J Clin Pharmacol. 1979 Apr 17;15(3):159-62. doi: 10.1007/BF00563099. Eur J Clin Pharmacol. 1979. PMID: 378670 Clinical Trial.
-
A trial of clenbuterol in bronchial asthma.Thorax. 1977 Dec;32(6):717-9. doi: 10.1136/thx.32.6.717. Thorax. 1977. PMID: 341407 Free PMC article. Clinical Trial.
-
Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe disease.FASEB J. 2013 Jan;27(1):34-44. doi: 10.1096/fj.12-207472. Epub 2012 Sep 19. FASEB J. 2013. PMID: 22993195 Free PMC article.